Latest Financial Reporting News

Page 7 of 46
Coast Entertainment Holdings Limited reported a robust 30.2% increase in revenue to $62.165 million for the half year ended December 2025, alongside a modest 1.4% rise in net profit. The company also completed a significant 10% on-market share buy-back.
Elise Vega
Elise Vega
13 Feb 2026
Invex Therapeutics reports a net loss of $715,582 for H1 2026 while advancing its Exenatide program targeting neurological diseases, alongside notable board reshuffles.
Ada Torres
Ada Torres
12 Feb 2026
Viva Leisure Limited has reported a robust half-year performance for the period ending 31 December 2025, with revenues climbing 17.6% and profit after tax soaring by 167.8%. The company’s strategic focus on franchise expansion and technology innovation is driving growth.
Victor Sage
Victor Sage
12 Feb 2026
Charter Hall Long WALE REIT reported a striking 209% surge in statutory profit for H1 2026, alongside a modest increase in distributions, underpinned by strategic acquisitions and a shift in accounting standards.
Eva Park
Eva Park
12 Feb 2026
Tamboran Resources Corporation reported a 26% reduction in half-year losses as it progresses key natural gas projects in Australia’s Beetaloo Basin and prepares for a major acquisition of Falcon Oil & Gas Ltd.
Maxwell Dee
Maxwell Dee
12 Feb 2026
Tamawood Limited has reported a robust interim financial performance for the half year ended December 2025, showcasing significant growth in revenue, profit, and net tangible assets per share. The company’s reinstated dividend reinvestment plan and upcoming dividend review add to investor interest.
Eva Park
Eva Park
11 Feb 2026
Centuria Industrial REIT has reported a strong first half for 2025, with total revenue surging over 20% and net profit rising by 10%, while distributions remain steady.
Victor Sage
Victor Sage
11 Feb 2026
Argenica Therapeutics has reported a significant increase in its half-year loss to $3.82 million, driven by reduced revenue and higher research and development expenses. The company continues to invest heavily in its neuroprotective drug candidate ARG-007 amid ongoing clinical trials.
Ada Torres
Ada Torres
11 Feb 2026
Elanor Investors Group has secured securityholder approval for a $125 million recapitalisation with Rockworth Capital Partners and the acquisition of Firmus Capital, marking a pivotal step in stabilising its balance sheet and positioning for growth.
Eva Park
Eva Park
10 Feb 2026
Regal Partners Global Investments Limited (ASX, RG1) has reported a remarkable turnaround with a $103.5 million profit after tax for the half-year ended 31 December 2025, alongside a 6.0 cent fully franked interim dividend and an active share buy-back program.
Victor Sage
Victor Sage
10 Feb 2026
American Uranium Limited has upgraded its U.S. trading status to the OTCQB Venture Market, enhancing liquidity and accessibility for North American investors. This move supports the company’s strategy to expand its U.S. shareholder base and increase visibility for its flagship uranium project in Wyoming.
Maxwell Dee
Maxwell Dee
10 Feb 2026
Region Group has reported a solid half-year financial performance ending December 2025, with increased revenue, net profit, and distributions, backed by an unqualified auditor review.
Eva Park
Eva Park
10 Feb 2026